Predicted protein targets (top 1)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EPHX1 | P07099 | 1/20 | 0.48 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Oxirane SCHEMBL28865425 | 0.93 | EPHX1 (0.50) | EPHX1 | |
| SCHEMBL10659 | 0.93 | — | — | |
| Ethane SCHEMBL28164531 | 0.90 | EPHX1 (0.52) | EPHX1 | |
| SCHEMBL29739832 | 0.90 | — | — | |
| Methoxymethane SCHEMBL28296588 | 0.86 | EPHX1 (0.48) | EPHX1 | |
| SCHEMBL11177747 | 0.86 | EPHX1 (0.48) | EPHX1 | |
| SCHEMBL21839289 | 0.84 | EPHX1 (0.73) | EPHX1 | |
| SCHEMBL43917 | 0.83 | EPHX1 (0.44) | EPHX1 | |
| SCHEMBL29010368 | 0.82 | EPHX1 (0.44) | EPHX1 | |
| SCHEMBL3187825 | 0.82 | EPHX1 (0.44) | EPHX1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 11 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3472876-B1 | CROSS-LINKING P-DOPANT FOR P-DOPING ORGANIC HOLE CONDUCTORS | MERCK PATENT GMBH (DE) | 2024-04-17 | — | — | EP | disclosed |
| CN-109643758-B | Crosslinked p-type dopants for p-type doping of organic hole conductors | 默克专利股份有限公司 | 2023-05-02 | — | — | CN | disclosed |
| EP-3472876-A1 | CROSS-LINKING P-DOPANT FOR P-DOPING ORGANIC HOLE CONDUCTORS | OSRAM OLED GmbH (DE) | 2019-04-24 | — | — | EP | disclosed |
| US-8262391-B2 | Dental composition based on silicone crosslinkable by cation process | BLUESTAR SILICONES FRANCE SAS (FR) | 2012-09-11 | — | — | US | disclosed |
| US-20100137468-A1 | DENTAL COMPOSITION BASED ON SILICONE CROSSLINKABLE BY CATION PROCESS | BLUESTAR SILICONES FRANCE (FR) | 2010-06-03 | — | — | US | disclosed |
| EP-2005246-A1 | CATIONIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME | DSMIP Assets B.V. (NL) | 2008-12-24 | — | — | EP | disclosed |
| WO-2007112921-A1 | CATIONIC COMPOSITION AND METHODS OF MAKING AND USING THE SAME | DSM IP ASSETS B.V. (NL) | 2007-10-11 | — | — | WO | disclosed |
| US-7247660-B2 | Dental composition based on silicone crosslinkable by cation process | RHODIA CHIMIE (FR) | 2007-07-24 | — | — | US | disclosed |
| US-20070149636-A1 | Dental composition based on silicone crosslinkable by cation process | FRANCES JEAN-MARC | 2007-06-28 | — | — | US | disclosed |
| US-20060178444-A1 | Dental composition based on silicone crosslinkable by cation process | BLUESTAR SILICONES FRANCE SAS (FR) | 2006-08-10 | — | — | US | disclosed |
| US-20040171717-A1 | Dental composition based on silicone crosslinkable by cation process | BLUESTAR SILICONES FRANCE SAS (FR) | 2004-09-02 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20100137468-A1 | DENTAL COMPOSITION BASED ON SILICONE CROSSLINKABLE BY CATION PROCESS | ALG3, TAS2R42, ITGB5 | EPHX1 1967/4885 |
| US-20060178444-A1 | Dental composition based on silicone crosslinkable by cation process | CAD, SEM1, SMCHD1 | EPHX1 2390/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.